BIOTECHNOLOGY VALUE FUND L P - 30 Jun 2025 SCHEDULE 13G/A Report for CRESCENT BIOPHARMA, INC. Ordinary Shares, $0.001 par value per share (CBIO)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
CRESCENT BIOPHARMA, INC. Ordinary Shares, $0.001 par value per share
Symbol
CBIO
Shares outstanding
13,892,523 shares
Disclosed Ownership
1,387,863 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 16:01:23 UTC
Date of event
30 Jun 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 5.1% 707,116 0 707,116 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 5.1% 707,116 0 707,116 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 4.3% 593,740 0 593,740 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 4.3% 593,740 0 593,740 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.4% 62,383 0 62,383 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.4% 62,383 0 62,383 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 9.4% 1,300,856 0 1,300,856 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 10% 1,387,863 0 1,387,863 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 10% 1,387,863 0 1,387,863 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 10% 1,387,863 0 1,387,863 /s/ Mark N. Lampert Mark N. Lampert